
chief executive and vice chairman Arun Kumar –Strides arcolab

Deepak Vaidya, chaiman
Headquartered in India, Strides Arcolab is a pharmaceutical company with a key focus on the development and manufacture of IP-led niche products, particularly sterile injectables. It is among the world’s largest manufacturers of soft gelatin capsules. With 14 world-class manufacturing facilities, an innovative R&D hub and a marketing network in 70 countries, Strides is well positioned to meet the demands of the global pharmaceutical industry and has partnered with several of the world’s leading pharmaceutical companies.
2 August 2013
Strides Arcolab’s HIV drug, which is generic version of Gilead Sciences’ Truvada, gets tentative approval from the US FDA.
Tentative approval implies that the drug has met all standards but cannot be marketed in the US due to existing patent protections Good news for HIV AIDS patients
FDA has granted tentative approval to India-based Strides Arcolab’s HIV drug emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg. The drug is a generic version of Truvada, 200 mg/300 mg tablets, which is manufactured by Gilead Sciences.


The product is indicated for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV)-1


………………
………….
…………..
EMTRICITABINE

credit-chemdrug


DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
.....

Reblogged this on MedCheminSingapore by Sushma Wang.
LikeLike
Reblogged this on GREEN MED CHEMISTRY.
LikeLike
Reblogged this on MedChemHot.Pakistan.
LikeLike